Jeffrey A. Gudin, MD, and Charles E. Argoff, MD, discuss factors that help determine whether they should administer immediate-release or rapid-onset analgesics for the management of breakthrough cancer pain. For more from this discussion, visit http://www.onclive.com/peer-exchange/...